Rafa Laboratories: Clinical Trials

4 trials sponsored by Rafa Laboratories, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Terminated 1
Phase 31Completed 1
Phase 41Terminated 1

Follow Rafa Laboratories: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Midazolam in Healthy Adults
Midazolam, Seizalam - Status Epilepticus
Phase 1CompletedRafa Laboratories402021-06-092022-03-17
Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
hypericum, fluoxetine - Depression
Phase 4TerminatedRafa Laboratories302009-01-012011-06-27
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
inhaled delta-8-THC 300mcg or 600mcg per dose - Cancer
Phase 2TerminatedRafa Laboratories62005-11-012020-12-23
Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation
Budesonide - Graft Vs Host Disease
Phase 3CompletedRafa Laboratories242001-01-012005-08-29

Conditions studied

Depression (1)  ·  Graft vs Host Disease (1)  ·  Nausea (1)  ·  Neoplasms (1)  ·  Status Epilepticus (1)  ·  Vomiting (1)

Interventions

Budesonide (1)  ·  Fluoxetine (1)  ·  Midazolam (1)  ·  Ondansetron (1)

Countries

Israel (3)  ·  United States (1)

Top investigators

Alan Apter, MD (1)  ·  Michael Y Shapira, MD (1)  ·  Nathan Cherny, MD (1)

Results publications

PMID 12874492, PMID 15910213